<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34498025</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>09</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1462-0332</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>61</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>05</Day>
            </PubDate>
          </JournalIssue>
          <Title>Rheumatology (Oxford, England)</Title>
          <ISOAbbreviation>Rheumatology (Oxford)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Incidence of chronic immune-mediated inflammatory diseases after diagnosis with Kawasaki disease: a population-based cohort study.</ArticleTitle>
        <Pagination>
          <StartPage>2095</StartPage>
          <EndPage>2103</EndPage>
          <MedlinePgn>2095-2103</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/rheumatology/keab680</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Kawasaki disease (KD) is an immune-mediated vasculitis of childhood with multi-organ inflammation. We determined the risk of subsequent immune-mediated inflammatory disease (IMID), including arthritis, type 1 diabetes, IBD, autoimmune liver disease, primary sclerosing cholangitis and multiple sclerosis.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a matched population-based cohort study using health administrative data from Ontario, Canada. Children aged &lt;18 years born between 1991 and 2016 diagnosed with KD (n = 3753) were matched to 5 non-KD controls from the general population (n = 18 749). We determined the incidence of IMIDs after resolution of KD. Three- and 12-month washout periods were used to exclude KD-related symptoms.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">There was an elevated risk of arthritis in KD patients compared with non-KD controls, starting 3 months after index date [103.0 vs 12.7 per 100 000 person-years (PYs); incidence rate ratio 8.07 (95% CI 4.95, 13.2); hazard ratio 8.08 (95% CI 4.95, 13.2), resulting in the overall incidence of IMIDs being elevated in KD patients (175.1 vs 68.0 per 100 000 PYs; incidence rate ratio 2.58 (95% CI 1.93, 3.43); hazard ratio 2.58, 95% CI 1.94, 3.43]. However, there was no increased risk for diabetes, IBD, autoimmune liver disease, primary sclerosing cholangitis or multiple sclerosis in KD patients. Similar results were observed using a 12-month washout period.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Children diagnosed with KD were at increased risk of arthritis following the acute KD event, but not other IMIDs. Health-care providers should monitor for arthritis in children following a diagnosis of KD.</AbstractText>
          <CopyrightInformation>© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Fung</LastName>
            <ForeName>Stephen G</ForeName>
            <Initials>SG</Initials>
            <AffiliationInfo>
              <Affiliation>Children's Hospital of Eastern Ontario Research Institute.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>ICES, Ottawa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Webster</LastName>
            <ForeName>Richard</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Children's Hospital of Eastern Ontario Research Institute.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kuenzig</LastName>
            <ForeName>M Ellen</ForeName>
            <Initials>ME</Initials>
            <Identifier Source="ORCID">0000-0002-3984-8426</Identifier>
            <AffiliationInfo>
              <Affiliation>Children's Hospital of Eastern Ontario Research Institute.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>ICES, Ottawa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Child Health Evaluative Sciences, SickKids Research Institute, The Hospital for Sick Children, Toronto.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Knight</LastName>
            <ForeName>Braden D</ForeName>
            <Initials>BD</Initials>
            <AffiliationInfo>
              <Affiliation>Children's Hospital of Eastern Ontario Research Institute.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>ICES, Ottawa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Ontario Child Health SUPPORT Unit, Ottawa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Batthish</LastName>
            <ForeName>Michelle</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, McMaster University, Hamilton.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Robinson</LastName>
            <ForeName>Cal</ForeName>
            <Initials>C</Initials>
            <Identifier Source="ORCID">0000-0002-2223-0646</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, McMaster University, Hamilton.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Paediatric Nephrology, Department of Paediatrics, The Hospital for Sick Children, Toronto.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chanchlani</LastName>
            <ForeName>Rahul</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>ICES, Ottawa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, McMaster University, Hamilton.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Paediatric Nephrology, Department of Paediatrics, The Hospital for Sick Children, Toronto.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Pediatric Nephrology, McMaster University, Hamilton.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Population Health Research Institute (PHRI), McMaster University, Hamilton.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Benchimol</LastName>
            <ForeName>Eric I</ForeName>
            <Initials>EI</Initials>
            <Identifier Source="ORCID">0000-0001-8855-3598</Identifier>
            <AffiliationInfo>
              <Affiliation>Children's Hospital of Eastern Ontario Research Institute.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>ICES, Ottawa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Child Health Evaluative Sciences, SickKids Research Institute, The Hospital for Sick Children, Toronto.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Paediatrics and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jimenez-Rivera</LastName>
            <ForeName>Carolina</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Children's Hospital of Eastern Ontario Research Institute.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <Acronym>CAPMC</Acronym>
            <Agency> CIHR</Agency>
            <Country>Canada</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Rheumatology (Oxford)</MedlineTA>
        <NlmUniqueID>100883501</NlmUniqueID>
        <ISSNLinking>1462-0324</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001168" MajorTopicYN="Y">Arthritis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015209" MajorTopicYN="Y">Cholangitis, Sclerosing</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015212" MajorTopicYN="Y">Inflammatory Bowel Diseases</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009080" MajorTopicYN="Y">Mucocutaneous Lymph Node Syndrome</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009103" MajorTopicYN="Y">Multiple Sclerosis</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009864" MajorTopicYN="N" Type="Geographic">Ontario</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">IBD</Keyword>
        <Keyword MajorTopicYN="N">Kawasaki disease</Keyword>
        <Keyword MajorTopicYN="N">arthritis</Keyword>
        <Keyword MajorTopicYN="N">autoimmune hepatitis</Keyword>
        <Keyword MajorTopicYN="N">health administrative data</Keyword>
        <Keyword MajorTopicYN="N">multiple sclerosis</Keyword>
        <Keyword MajorTopicYN="N">pediatrics</Keyword>
        <Keyword MajorTopicYN="N">primary sclerosing cholangitis</Keyword>
        <Keyword MajorTopicYN="N">routinely collected health data</Keyword>
        <Keyword MajorTopicYN="N">type 1 diabetes mellitus</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2022</Year>
          <Month>9</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>55</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34498025</ArticleId>
        <ArticleId IdType="pmc">PMC9071560</ArticleId>
        <ArticleId IdType="doi">10.1093/rheumatology/keab680</ArticleId>
        <ArticleId IdType="pii">6366560</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
McCrindle BW, Rowley AH, Newburger JW. 
et al.; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 2017;135:e927–99.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28356445</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Dietz SM, van Stijn D, Burgner D. 
et al.
Dissecting Kawasaki disease: a state-of-the-art review. Eur J Pediatr 2017;176:995–1009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5511310</ArticleId>
            <ArticleId IdType="pubmed">28656474</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Pawłowska J, Naorniakowska M, Liber A.. 
Liver involvement in children with collagen vascular diseases. Clin Exp Hepatol 2015;1:117–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5497418</ArticleId>
            <ArticleId IdType="pubmed">28856258</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Manlhiot C, Mueller B, O’Shea S. 
et al.
Environmental epidemiology of Kawasaki disease: linking disease etiology, pathogenesis and global distribution. PLoS One 2018;13:e0191087.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5802431</ArticleId>
            <ArticleId IdType="pubmed">29415012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Colomba C, La Placa S, Saporito L. 
et al.
Intestinal involvement in Kawasaki disease. J Pediatr 2018;202:186–93.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30029859</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Dong S, Bout-Tabaku S, Texter K, Jaggi P.. 
Diagnosis of systemic-onset juvenile idiopathic arthritis after treatment for presumed Kawasaki disease. J Pediatr 2015;166:1283–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25771391</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Watanabe T.
Clinical features of acute kidney injury in patients with Kawasaki disease. World J Clin Pediatr 2018;7:83–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6125143</ArticleId>
            <ArticleId IdType="pubmed">30191137</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Stagi S, Simonini G, Ricci L, de Martino M, Falcini F.. 
Coeliac disease in patients with Kawasaki disease. Is there a link?
Rheumatology (Oxford)
2006;45:847–50.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16418194</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Rosencrantz RA, Huang T, Sonke PY, Tewari D, Chander PN.. 
Autoimmune sclerosing cholangitis: an atypical association with Kawasaki disease. Hepatology 2016;64:2253–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27333792</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Sidiropoulos M, Skuy B.. 
Crohn’s disease presenting with atypical mucocutaneous lesions in an 11 year old boy. Mcgill J Med 2011;13:28.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3277335</ArticleId>
            <ArticleId IdType="pubmed">22363181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Shaikh S, Ishaque S, Saleem T.. 
Incomplete, atypical Kawasaki disease or evolving systemic juvenile idiopathic arthritis: a case report. Cases J 2009;2:6962.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2769330</ArticleId>
            <ArticleId IdType="pubmed">19918500</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chanchlani R, Nash DM, McArthur E. 
et al.
Secular trends in incidence, modality and mortality with dialysis receiving AKI in children in Ontario: a population-based cohort study. Clin J Am Soc Nephrol 2019;14:1288–96.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6730522</ArticleId>
            <ArticleId IdType="pubmed">31444174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Manlhiot C, O’Shea S, Bernknopf B. 
et al.
Epidemiology of Kawasaki Disease in Canada 2004 to 2014: comparison of surveillance using administrative data vs periodic medical record review. Can J Cardiol 2018;34:303–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29395706</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Benchimol EI, Guttmann A, Griffiths AM. 
et al.
Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data. Gut 2009;58:1490–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19651626</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Benchimol EI, Guttmann A, Mack DR. 
et al.
Validation of international algorithms to identify adults with inflammatory bowel disease in health administrative data from Ontario, Canada. J Clin Epidemiol 2014;67:887–96.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24774473</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Widdifield J, Ivers NM, Young J. 
et al.
Development and validation of an administrative data algorithm to estimate the disease burden and epidemiology of multiple sclerosis in Ontario, Canada. Mult Scler 2015;21:1045–54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25392338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Molodecky NA, Myers RP, Barkema HW, Quan H, Kaplan GG.. 
Validity of administrative data for the diagnosis of primary sclerosing cholangitis: a population-based study. Liver Int 2011;31:712–20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21457444</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Guttmann A, Nakhla M, Henderson M. 
et al.
Validation of a health administrative data algorithm for assessing the epidemiology of diabetes in Canadian children. Pediatr Diabetes 2010;11:122–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19500278</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hux JE, Ivis F, Flintoft V, Bica A.. 
Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 2002;25:512–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11874939</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Widdifield J, Bernatsky S, Paterson JM. 
et al.
Accuracy of Canadian health administrative databases in identifying patients with rheumatoid arthritis: a validation study using the medical records of rheumatologists. Arthritis Care Res 2013;65:1582–91.</Citation>
        </Reference>
        <Reference>
          <Citation>
Widdifield J, Bombardier C, Bernatsky S. 
et al.
An administrative data validation study of the accuracy of algorithms for identifying rheumatoid arthritis: the influence of the reference standard on algorithm performance. BMC Musculoskelet Disord 2014;15:216.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4078363</ArticleId>
            <ArticleId IdType="pubmed">24956925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Shiff NJ, Oen K, Rabbani R, Lix LM.. 
Validation of administrative case ascertainment algorithms for chronic childhood arthritis in Manitoba, Canada. Rheumatol Int 2017;37:1575–84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28502061</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Robinson C, Chanchlani R, Gayowsky A. 
et al.
Incidence and short-term outcomes of Kawasaki disease. Pediatr Res 2021; Advance Access published 30 March 2021, doi: 10.1038/s41390-021-01496-5</Citation>
        </Reference>
        <Reference>
          <Citation>
Feudtner C, Feinstein JA, Zhong W, Hall M, Dai D.. 
Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation. BMC Pediatr 2014;14:199.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4134331</ArticleId>
            <ArticleId IdType="pubmed">25102958</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Gong GW, McCrindle BW, Ching JC, Yeung RS.. 
Arthritis presenting during the acute phase of Kawasaki disease. J Pediatr 2006;148:800–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16769390</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lee KY, Oh JH, Han JW, Lee JS, Lee BC.. 
Arthritis in Kawasaki disease after responding to intravenous immunoglobulin treatment. Eur J Pediatr 2005; 164:451–2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15782294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Martins A, Conde M, Brito M, Gouveia C.. 
Arthritis in Kawasaki disease: a poorly recognised manifestation. J Paediatr Child Health 2018;54:1371–4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29943869</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Izumi G, Narugami M, Saita Y. 
et al.
Arthritis associated with Kawasaki disease: MRI findings and serum matrix metalloproteinase-3 profiles. Pediatr Int 2011;53:1087–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22181570</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Rigante D, Valentini P, Onesimo R. 
et al.
Incomplete Kawasaki syndrome followed by systemic onset-juvenile idiopathic arthritis mimicking Kawasaki syndrome. Rheumatol Int 2010;30:535–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19455336</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Petty RE, Southwood TR, Manners P. 
et al.; International League of Associations for Rheumatology. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31:390–2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14760812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Komatsu H, Tateno A.. 
Failure to distinguish systemic-onset juvenile idiopathic arthritis from incomplete Kawasaki disease in an infant. J Paediatr Child Health 2007;43:707–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17854457</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Pilania RK, Bhattarai D, Singh S.. 
Controversies in diagnosis and management of Kawasaki disease. World J Clin Pediatr 2018;7:27–35.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5803562</ArticleId>
            <ArticleId IdType="pubmed">29456929</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
